Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology

The Long Road: Prognosis and the Path to Healing

At a Glance

Recovery from postcardiotomy right ventricular failure is a gradual process requiring careful weaning from life support machines. While survival rates are challenging, patients who successfully wean can often achieve a good quality of life through intensive cardiac rehabilitation.

The road to recovery after postcardiotomy right ventricular failure (RVF) is often long and requires immense patience. While the initial crisis may have passed, the “weaning” phase—where the heart is asked to take back its workload—is a critical and slow process. It is important to understand the reality of this condition: it is a high-stakes recovery, but for those who stabilize, a return to a good quality of life is possible [1][2].

The “Test of Strength”: The Weaning Process

Weaning is the medical term for slowly decreasing life support (medications and machines) to see if the heart is strong enough to work on its own [3]. This is not done all at once; it is a highly protocolized “test of strength” [4]. Depending on the patient’s condition and the support used (like ECMO or RVADs, discussed in When the Heart Needs a Machine), this process typically takes several days to several weeks.

  • The “Turn-Down” Trial: For patients on mechanical support, doctors will slowly turn down the pump’s speed [5].
  • Monitoring the Response: While the machine is dialed back, the team uses echocardiography (ultrasound) to watch the right ventricle’s movement and uses pressure monitors to track the PAPi (an index of heart power) [6][7].
  • Setbacks: It is common for a patient to fail a weaning trial. This is often called weaning-related shock and can be caused by the heart not being ready or by secondary issues like infection [8]. If this happens, the support is turned back up, and the heart is given more time to rest [9].

What the Statistics Tell Us

It is important to be honest about the severity of this condition. Patients who require mechanical support for RVF face a difficult climb.

  • Survival Realities: Survival rates for patients needing mechanical support after heart surgery are lower than for those who recover with medications alone [10].
  • The Silver Lining: Research shows that patients who are successfully weaned from support often report a health-related quality of life similar to other heart surgery patients [2]. The right ventricle has a unique ability to “remodel” and heal if it survives the initial injury [11].

When the Heart Does Not Recover

In some cases, the damage to the right heart is too severe for it to recover on its own. If multiple weaning trials fail, the medical team will begin discussing “advanced therapies.”

  • Heart Transplant: If the patient is a candidate, a heart transplant remains the gold standard for long-term survival when the heart muscle cannot recover [12]. Temporary machines can sometimes serve as a “bridge” to keep the patient stable until a donor heart is found [13][14].
  • Durable VADs: If a transplant isn’t an option, doctors may discuss a BiVAD (Biventricular Assist Device), which is a more permanent pump for both sides of the heart [15].

Life After the ICU

Recovery doesn’t end when the tubes are removed. Most survivors of postcardiotomy RVF will require intensive cardiac rehabilitation. This includes physical therapy to rebuild muscles that have weakened during weeks in the ICU [16]. Many patients will also need to manage chronic heart failure with long-term medications to keep the lung pressures low and the heart muscle supported [17]. Though the journey is arduous, many families find that the “new normal” eventually includes a return to many of the activities their loved one enjoyed before surgery.

Common questions in this guide

What does it mean to wean from life support after heart surgery?
Weaning is the slow, step-by-step process of decreasing life support medications and machines to test if the heart is strong enough to pump on its own. Doctors carefully monitor the heart's response using ultrasound and pressure monitors during this time.
What causes a setback during the weaning process?
Setbacks, often called weaning-related shock, happen when the heart is not yet ready to take over the workload. They can also be triggered by secondary complications like infections, requiring doctors to temporarily increase support so the heart can rest.
What happens if the heart cannot be weaned from the machines?
If multiple weaning trials fail and the heart cannot recover on its own, the medical team will discuss advanced therapies. These options may include an evaluation for a heart transplant or a permanent mechanical pump like a BiVAD.
What does recovery look like after leaving the ICU?
Recovery requires intensive cardiac rehabilitation, including physical therapy to rebuild muscles weakened during the hospital stay. Many patients will also need long-term medications to manage chronic heart failure and support the heart muscle.
Can you have a good quality of life after postcardiotomy RVF?
Yes. While the condition is very serious and survival can be challenging, patients who successfully wean from mechanical support often achieve a quality of life similar to other heart surgery survivors once they complete rehabilitation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific milestones on the daily echocardiogram are you looking for before we attempt a weaning trial?
  2. 2.During the last 'turn-down' trial, how did the right heart's pressures (PAPi) and movement (TAPSE) respond?
  3. 3.If we cannot successfully wean from the machines, what is the 'Plan B' (e.g., durable VAD or transplant evaluation)?
  4. 4.What are we doing today to prevent complications like sepsis that could set back the weaning process?
  5. 5.What kind of specialized rehabilitation will my loved one need once they are stable enough to leave the ICU?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Predictors of health-related quality of life after cardiac surgery: a systematic review.

    Sanders J, Bowden T, Woolfe-Loftus N, et al.

    Health and quality of life outcomes 2022; (20(1)):79 doi:10.1186/s12955-022-01980-4.

    PMID: 35585633
  2. 2

    Quality of Life and Mid-Term Survival in Patients Receiving Extracorporeal Membrane Oxygenation After Cardiac Surgery.

    Shao C, Wang L, Yang F, et al.

    ASAIO journal (American Society for Artificial Internal Organs : 1992) 2022; (68(3)):349-355 doi:10.1097/MAT.0000000000001473.

    PMID: 35213884
  3. 3

    Temporary Mechanical Circulatory Support in Cardiogenic Shock: Executive Summary of the Joint Consensus Reports of the PeriOperative Quality Initiative and the Enhanced Recovery After Surgery Cardiac Society.

    Grant MC, Kanwar MK, Spelde AE, et al.

    The Annals of thoracic surgery 2025; (120(2)):194-201 doi:10.1016/j.athoracsur.2025.03.024.

    PMID: 40185355
  4. 4

    Escalation and De-escalation of Temporary Mechanical Circulatory Support: Joint Consensus Report of the PeriOperative Quality Initiative and the Enhanced Recovery After Surgery Cardiac Society.

    Spelde AE, Barron LM, Cangut B, et al.

    The Annals of thoracic surgery 2025; (120(2)):213-224 doi:10.1016/j.athoracsur.2025.01.038.

    PMID: 40187586
  5. 5

    Hemodynamic Ramp Test in Cardiogenic Shock Supported by Microaxial Flow Pump: Protocol Description, Feasibility, and Hemodynamic Response.

    Ikeda Y, Iikura S, Nakahara S, et al.

    ASAIO journal (American Society for Artificial Internal Organs : 1992) 2026; (72(8)):669-675 doi:10.1097/MAT.0000000000002555.

    PMID: 40981641
  6. 6

    Echocardiographic parameters for weaning from extracorporeal membrane oxygenation-the role of longitudinal function and cardiac time intervals.

    Tavazzi G, Colombo CNJ, Klersy C, et al.

    European heart journal. Cardiovascular Imaging 2025; (26(2)):359-367 doi:10.1093/ehjci/jeae274.

    PMID: 39441992
  7. 7

    Association Between Pulmonary Artery Pulsatility Index and Radial Artery Pulse Pressure and Successful Separation from Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation: A French Single-Center Retrospective Study From 2017 to 2021.

    Duong VD, Aludaat C, Kouadri G, et al.

    Journal of cardiothoracic and vascular anesthesia 2025; (39(2)):429-436 doi:10.1053/j.jvca.2024.11.013.

    PMID: 39617653
  8. 8

    Weaning-Related Shock in Patients With ECMO: Incidence, Mortality, and Predisposing Factors.

    Tohme J, Piat C, Aissat N, et al.

    Journal of cardiothoracic and vascular anesthesia 2021; (35(1)):41-47 doi:10.1053/j.jvca.2020.07.069.

    PMID: 32828655
  9. 9

    Extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation.

    Riebandt J, Haberl T, Wiedemann D, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2018; (53(3)):590-595 doi:10.1093/ejcts/ezx349.

    PMID: 29045747
  10. 10

    Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience.

    Nersesian G, Hennig F, Müller M, et al.

    Annals of cardiothoracic surgery 2019; (8(1)):76-83 doi:10.21037/acs.2018.12.01.

    PMID: 30854315
  11. 11

    Right ventricular systolic function is associated with health-related quality of life: a cross-sectional study in community-dwelling populations.

    Liu YT, Lai JZ, Zhai FF, et al.

    Annals of translational medicine 2021; (9(8)):640 doi:10.21037/atm-20-6845.

    PMID: 33987338
  12. 12

    Right ventricular failure after LVAD support: A challenging case of bridge to heart transplantation in end-stage dilated cardiomyopathy.

    Suciu H, Anitei ED, Calburean P, Harpa MM

    Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) 2026; (12(1)):102-109 doi:10.2478/jccm-2025-0038.

    PMID: 41704333
  13. 13

    Impella RP as a bridge to cardiac transplant for refractory late right ventricular failure in setting of left ventricular assist device.

    Randhawa VK, Hoffman K, Bock A, et al.

    ESC heart failure 2020; (7(4)):1972-1975 doi:10.1002/ehf2.12685.

    PMID: 32426932
  14. 14

    ECMO in cardiogenic shock and bridge to heart transplant.

    Chakaramakkil MJ, Sivathasan C

    Indian journal of thoracic and cardiovascular surgery 2021; (37(Suppl 2)):319-326 doi:10.1007/s12055-020-00923-2.

    PMID: 33967452
  15. 15

    Long-term paracorporeal pulsatile mechanical circulatory support in adolescent and adult patients.

    Kremer J, El-Dor A, Sommer W, et al.

    Interactive cardiovascular and thoracic surgery 2022; (35(3)) doi:10.1093/icvts/ivac107.

    PMID: 35532167
  16. 16

    The rest of the story: Long-term, patient-reported outcomes in cardiac surgery.

    Chancellor WZ, Kron IL

    The Journal of thoracic and cardiovascular surgery 2018; (156(6)):2191 doi:10.1016/j.jtcvs.2018.05.093.

    PMID: 30007782
  17. 17

    Effect of Cardiac Surgery on One-Year Patient-Reported Outcomes: A Prospective Cohort Study.

    Charles EJ, Mehaffey JH, Hawkins RB, et al.

    The Annals of thoracic surgery 2021; (112(5)):1410-1416 doi:10.1016/j.athoracsur.2020.09.061.

    PMID: 33309733

This page provides information on postcardiotomy right ventricular failure recovery for educational purposes. Always consult your ICU care team or cardiologist regarding specific weaning protocols, prognosis, and treatment options.

Get notified when new evidence is published on Postcardiotomy right ventricular failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.